JYSZ2300045 | 谷赖胰岛素注射液 | insulin glulisine | Injection | Biological Products | License Renew | 2023-10-09 | | | | | view |
JYSZ2300044 | 谷赖胰岛素注射液 | insulin glulisine | Injection | Biological Products | License Renew | 2023-10-09 | | | | | view |
JYSZ2300043 | 谷赖胰岛素注射液 | insulin glulisine | Injection | Biological Products | License Renew | 2023-10-09 | | | | | view |
JYSZ2300042 | 谷赖胰岛素注射液 | insulin glulisine | Injection | Biological Products | License Renew | 2023-10-09 | | | | | view |
JYSZ1900022 | 谷赖胰岛素注射液 | insulin glulisine | Injection | Biological Products | License Renew | 2019-05-20 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Certificate Issued | 2019-10-28 | view |
JYSZ1900021 | 谷赖胰岛素注射液 | insulin glulisine | Injection | Biological Products | License Renew | 2019-05-10 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Certificate Issued | 2019-10-28 | view |
JYSZ1900020 | 谷赖胰岛素注射液 | insulin glulisine | Injection | Biological Products | License Renew | 2019-05-20 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Certificate Issued | 2019-10-28 | view |
JYSZ1900019 | 谷赖胰岛素注射液 | insulin glulisine | Injection | Biological Products | License Renew | 2019-05-20 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Certificate Issued | 2019-10-28 | view |
JYSF1900021 | 谷赖胰岛素注射液 | insulin glulisine | Injection | Biological Products | Supplementary Application | 2019-12-03 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Certificate Issued | 2019-12-19 | view |
JYSB2100068 | 谷赖胰岛素注射液 | insulin glulisine | Injection | Biological Products | Supplementary Application | 2021-03-10 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | In Review | 2021-03-10 | view |
JYSB2100067 | 谷赖胰岛素注射液 | insulin glulisine | Injection | Biological Products | Supplementary Application | 2021-03-10 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | In Review | 2021-03-10 | view |
JYSB2100066 | 谷赖胰岛素注射液 | insulin glulisine | Injection | Biological Products | Supplementary Application | 2021-03-10 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | In Review | 2021-03-10 | view |
JYSB2000324 | 谷赖胰岛素注射液 | insulin glulisine | Injection | Biological Products | Supplementary Application | 2020-06-29 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Filed | 2020-07-01 | view |
JYSB2000323 | 谷赖胰岛素注射液 | insulin glulisine | Injection | Biological Products | Supplementary Application | 2020-06-29 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Filed | 2020-07-01 | view |
JYSB2000322 | 谷赖胰岛素注射液 | insulin glulisine | Injection | Biological Products | Supplementary Application | 2020-06-29 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Filed | 2020-07-01 | view |
JYSB1900331 | 谷赖胰岛素注射液 | insulin glulisine | Injection | Biological Products | Supplementary Application | 2019-11-26 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Filed | 2019-12-10 | view |
JYSB1700217 | 谷赖胰岛素注射液 | insulin glulisine | Injection | Biological Products | Supplementary Application | 2017-12-21 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Certificate Issued | 2019-04-25 | view |
JYSB1700216 | 谷赖胰岛素注射液 | insulin glulisine | Injection | Biological Products | Supplementary Application | 2017-12-01 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Certificate Issued | 2019-04-25 | view |
JYSB1700215 | 谷赖胰岛素注射液 | insulin glulisine | Injection | Biological Products | Supplementary Application | 2017-12-28 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Certificate Issued | 2019-04-25 | view |
JYSB1700214 | 谷赖胰岛素注射液 | insulin glulisine | Injection | Biological Products | Supplementary Application | 2017-12-28 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Certificate Issued | 2018-12-25 | view |